Article
Genotyping of thrombotic risk factors by MALDI-TOF mass spectrometry.
Clinical biochemistry - 1 Oct 2001
Humeny A, Bonk T, Berkholz A, Wildt L, Becker C M
Abstract excerpt
OBJECTIVES: Individual risk of thrombotic disease is highly associated with allelic sequence variations in the blood clotting factor V (F5) and factor II (F2) genes. The polymorphism (G1691A) in F5 causing the amino acid substitution R506Q and a genetic variation in the 3' untranslated region of F2 (G20210A) are highly prevalent in the Caucasian population. These findings raise the need for an efficient,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
